Gene Expression Profile in Microglia following Ischemia-Reperfusion Injury.
- Author:
Ju Hyeon OH
1
;
Hyung Soo HAN
;
Jae Sik PARK
Author Information
1. Department of Physiology, School of Medicine, Kyungpook National University, Daegu, Korea. jaespark@knu.ac.kr
- Publication Type:Original Article
- Keywords:
Gene expression;
Microglia;
Ischemia-reperfusion;
Microarray
- MeSH:
Animals;
Brain;
Brain Diseases;
Gene Expression*;
Glucose;
Mice;
Microarray Analysis;
Microglia*;
Oxygen;
Pathologic Processes;
Reperfusion;
Reperfusion Injury*;
RNA, Messenger;
Stroke;
Transcriptome*;
Tumor Necrosis Factor-alpha
- From:The Korean Journal of Physiology and Pharmacology
2006;10(4):173-180
- CountryRepublic of Korea
- Language:English
-
Abstract:
Microglial activation is thought to play a role in the pathogenesis of many brain disorders. Therefore, understanding the response of microglia to noxious stimuli may provide insights into their role in disorders such as stroke and neurodegeneration. Many genes involved in this response have been identified individually, but not systematically. In this regards, the microarray system permitted to screen a large number of genes in biological or pathological processes. Therefore, we used microarray technology to evaluate the effect of oxygen glucose deprivation (OGD) and reperfusion on gene expression in microglia under ischemia-like and activating conditions. Primary microglial cultures were prepared from postnatal mice brain. The cells were exposed to 4 hrs of OGD and 1 h of reperfusion at 37 degrees C. Isolated mRNA were run on GeneChips. After OGD and reperfusion, > 2-fold increases of 90 genes and > 2-fold decrease of 41 genes were found. Among the genes differentially increased by OGD and reperfusion in microglia were inflammatory and immune related genes such as prostaglandin E synthase, IL-1beta, and TNF-alpha. Microarray analysis of gene expression may be useful for elucidating novel molecular mediators of microglial reaction to reperfusion injury and provide insights into the molecular basis of brain disorders.
